US 11840686
Modulation of prekallikrein (PKK) expression
granted A61KA61K31/7088A61K38/36
Quick answer
US patent 11840686 (Modulation of prekallikrein (PKK) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/7088, A61K38/36, A61P, A61P29/00